|
Chifeng Sunrise Pharmaceutical Technology Co., Ltd.
|
Nitrendipine
biology science and technology co., LTD., founded in 2019 - 10-21, the registered capital of 1,000,000, the legal representative for li shiwen, business status for survival, industrial and commercial registration number is 150404021788384, the registered address for Inner Mongolia autonomous region chifeng songshan songshan industrial park food park standardization plant no. 3, business scope includes biology technology promotion and development; |
Send Inquiry
|
|
Shaanxi Xi Yue Pharmaceutical Co., LTD
|
Nitrendipine is a dihydropyridine calcium ion antagonist with the molecular formula C18H20N2O6 and number 39562-70-4. It is mainly used to treat hypertension and angina pectoris. By selectively blocking the calcium channels of v smooth muscle, it dilates peripheral arteries, reduces blood pressure, and improves myocardial blood supply. Its characteristics include slow onset, long-lasting action (once or daily dosing), and minimal impact on the cardiac conduction system. Common dosage forms include tablets (such as 10 mg/tablet), which should be used as by a doctor. It may cause side effects such as headaches and facial flushing, and should be used with caution in pregnant women and patients with severe aortic stenosis This drug has been used since the 1980s and is still one of the first-line antihypertensive medications in clinical practice |
Send Inquiry
|
Pharma Sources Insight July 2025
